NEXICLON
Dead / Cancelled — Cancelled — Section 8 (as of 23 Mar 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85033595
- Registration number
- 4013428
- Mark type
- Stylized text
- Filed
- 08 May 2010
- Published for opposition
- 19 Oct 2010
- Registered
- 16 Aug 2011
- Attorney of record
- Richard S. Stockton
Goods and services
- Class 005 — Pharmaceuticals: Extended release tablets, extended release chewable tablets and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension, Tourette's syndrome, attention deficit hyperactivity disorder and autism
Owner
- TRIS PHARMA, INC., MONMOUTH JUNCTION, NJ, US
- NEXTWAVE PHARMACEUTICALS INCORPORATED, Vernon Hills, IL, US
- NEXTWAVE PHARMACEUTICALS INCORPORATED, Vernon Hills, IL, US
- NEXTWAVE PHARMACEUTICALS INCORPORATED, Vernon Hills, IL, US
Prosecution history
- 31 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Mar 2018 — CANCELLED SEC. 8 (6-YR)
- 20 Sept 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 27 Jun 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Aug 2011 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jul 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 08 Jul 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jun 2011 — USE AMENDMENT FILED
- 21 Jun 2011 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jun 2011 — TEAS STATEMENT OF USE RECEIVED
- 14 Dec 2010 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Oct 2010 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED